XRF Scientific (XRF) H2 2025 earnings summary

Executive summary

• Achieved record net profit after tax (NPAT) of $10.4m, up 17% year-over-year, despite a 1% decrease in sales revenue to $59.5m.

• Strong performance in Consumables and Orbis Mining, with international sales growth in Asia, Americas, and Europe.

• Fully franked final dividend of 4.5 cents per share declared, up 15% from last year.

• Balance sheet remains robust with $12.2m in cash and $1.1m in debt at year-end.

Financial highlights

• Sales revenue: $59.5m, down 1.1% from $60.1m in FY24.

• NPAT attributable to members: $10.38m, up 16.9% year-over-year.

• Basic and diluted EPS: 7.4 cents, up 15% from 6.4 cents in FY24.

• Operating cash flow: $10.1m, up 25% from $8.1m in FY24.

• Final dividend paid: $5.44m (3.9 cents per share), with a new final dividend of 4.5 cents per share declared.

Outlook and guidance

• Focus on increasing profitability and market capitalisation through geographic expansion and new product development.

• Continued pursuit of acquisition opportunities in complementary sectors.